Scholarly Index
Harry P. Erba
Duke Medical Center; 18,621 total citations; 481 total publications; best world rank #56
Duke Medical Center
18,621Total citations
481Total publications
63H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Acute Myeloid Leukemia Research | Lifetime | 258 | US 132 | 99.25 |
| Histone Deacetylase Inhibitors Research | Lifetime | 166 | US 102 | 98.26 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 261 | US 135 | 98.71 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 743 | US 343 | 98.17 |
| Acute Lymphoblastic Leukemia research | Lifetime | 643 | US 310 | 97.75 |
| Multiple Myeloma Research and Treatments | Lifetime | 524 | US 236 | 97.37 |
| Protein Degradation and Inhibitors | Lifetime | 407 | US 217 | 96.90 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 375 | US 167 | 97.29 |
| Acute Myeloid Leukemia Research | 2021-2025 | 79 | US 50 | 99.13 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 56 | US 36 | 98.95 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 122 | US 63 | 98.41 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 221 | US 118 | 94.81 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 470 | US 233 | 93.08 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 601 | US 280 | 92.16 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 818 | US 228 | 76.44 |